Surgery Partners, Inc. (SGRY) Misses Q3 EPS by 7c, Offers Guidance

Surgery Partners, Inc. (NASDAQ: SGRY) reported Q3 EPS of ($0.02), $0.07 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $620.6 million versus the consensus estimate of $634.98 million.

GUIDANCE:

Surgery Partners, Inc. sees FY2022 revenue of $2.5-2.55 billion, versus the consensus of $2.54 billion.

• reaffirms projected 2022 Adjusted EBITDA of $375 million to $385 million

For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Carnival shares drop despite earnings beat on weak guidance
• BofA lists top 5 themes driving next $1tn in incremental semi sales